Saz-Leal, P.; Ligon, M.M.; Diez-Rivero, C.M.; GarcÃa-Ayuso, D.; Mohanty, S.; Viñuela, M.; Real-Arévalo, I.; Conejero, L.; Brauner, A.; Subiza, J.L.;
et al. MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines 2024, 12, 535.
https://doi.org/10.3390/vaccines12050535
AMA Style
Saz-Leal P, Ligon MM, Diez-Rivero CM, GarcÃa-Ayuso D, Mohanty S, Viñuela M, Real-Arévalo I, Conejero L, Brauner A, Subiza JL,
et al. MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines. 2024; 12(5):535.
https://doi.org/10.3390/vaccines12050535
Chicago/Turabian Style
Saz-Leal, Paula, Marianne Morris Ligon, Carmen MarÃa Diez-Rivero, Diego GarcÃa-Ayuso, Soumitra Mohanty, Marcos Viñuela, Irene Real-Arévalo, Laura Conejero, Annelie Brauner, José Luis Subiza,
and et al. 2024. "MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection" Vaccines 12, no. 5: 535.
https://doi.org/10.3390/vaccines12050535
APA Style
Saz-Leal, P., Ligon, M. M., Diez-Rivero, C. M., GarcÃa-Ayuso, D., Mohanty, S., Viñuela, M., Real-Arévalo, I., Conejero, L., Brauner, A., Subiza, J. L., & Mysorekar, I. U.
(2024). MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection. Vaccines, 12(5), 535.
https://doi.org/10.3390/vaccines12050535